ImmunoHorizons

4.6k citations
515 papers · · active since 1951

Impact in

  • Immunology top 10%
    • Immune Cell Function and Interaction
    • T-cell and B-cell Immunology
    • Immunotherapy and Immune Responses
    • Immune Response and Inflammation
    • IL-33, ST2, and ILC Pathways
    • Immune cells in cancer
    • interferon and immune responses

Papers in

    • Immune Cell Function and Interaction 189
    • T-cell and B-cell Immunology 141
    • Immunotherapy and Immune Responses 60
    • Immune Response and Inflammation 60
    • IL-33, ST2, and ILC Pathways 26
    • SARS-CoV-2 and COVID-19 Research 23

ImmunoHorizons

453 papers receiving 4.6k citations

Peers

ImmunoHorizons
Comparison fields: 5 of 131
  • Immunology 2.1k
  • Infectious Diseases 450
  • Biological Psychiatry 54
  • Epidemiology 646
  • Oncology 497
Replace Human Antibodies with:
Human Antibodies United States
Biologics United States
International Journal of Clinical & Laboratory Research Italy
Drugs in Context United States
Therapeutic Advances in Musculoskeletal Disease United States
Current Protocols in Cytometry United States
Drug Discoveries & Therapeutics Japan
Inflammation and Regeneration Japan
Intestinal Research South Korea
Inflammation & Allergy - Drug Targets United States
ImmunoHorizons relative to Human Antibodies United States Human Antibodies's profile →
Citations per field
00.5×2×4×6×7.4×
Human Antibodies · 1×
Citations per year

Countries where authors publish in ImmunoHorizons

Since Specialization
Citations

This map shows the geographic impact of research published in ImmunoHorizons. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers published in ImmunoHorizons with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites ImmunoHorizons more than expected).

Fields of papers published in ImmunoHorizons

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers published in ImmunoHorizons. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers published in ImmunoHorizons.

About ImmunoHorizons

The 515 papers published in ImmunoHorizons in the last decades have received a total of 4.6k indexed citations . Papers published in ImmunoHorizons usually cover Immunology (342 papers), Infectious Diseases (59 papers), Immunology and Allergy (17 papers), Oncology (65 papers) and Epidemiology (77 papers) specifically the topics of Immune Cell Function and Interaction (189 papers), T-cell and B-cell Immunology (141 papers), Immunotherapy and Immune Responses (60 papers), Immune Response and Inflammation (60 papers), CAR-T cell therapy research (34 papers), IL-33, ST2, and ILC Pathways (26 papers), SARS-CoV-2 and COVID-19 Research (23 papers) and Asthma and respiratory diseases (20 papers). The most active scholars publishing in ImmunoHorizons are David J. Dowling, Lauren A. Zenewicz, Thirumala‐Devi Kanneganti, Rajendra Karki, Balabhaskararao Kancharana, R. K. Subbarao Malireddi, Sallie R. Permar, Geeta K. Swamy, David R. Martinez and Genevieve G. Fouda.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore journals with similar magnitude of impact